Acute myeloid leukemia: Difference between revisions

	Acute myeloid leukemia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Acute myeloid leukemia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardigram
Chest X Ray
Echocardiograph and Ultrasound
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Acute myeloid leukemia On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Acute myeloid leukemia All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Acute myeloid leukemia
CDC on Acute myeloid leukemia
Acute myeloid leukemia in the news
Blogs on Acute myeloid leukemia
Directions to Hospitals Treating Acute myeloid leukemia
Risk calculators and risk factors for Acute myeloid leukemia

Revision as of 18:31, 22 August 2012

For patient information click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]

Synonyms and keywords: AML; acute granulocytic leukaemia; acute myeloblastic leukemia; acute myelogenous leukemia

@@ Line 39: / Line 39: @@
 ==Treatment==
-[[Acute myeloid leukemia medical therapy#Overview|Medical Therapy]] | [[Acute myeloid leukemia medical therapy#Chemotherapy|Chemotherapy]] | [[Acute myeloid leukemia medical therapy#Relapsed AML|Relapsed AML]] | [[Acute myeloid leukemia medical therapy#Supportive Therapy|Supportive Therapy]]
+[[Acute myeloid leukemia medical therapy#Overview|Medical Therapy Overview]] | [[Acute myeloid leukemia medical therapy#Chemotherapy|Chemotherapy]] | [[Acute myeloid leukemia medical therapy#Relapsed AML|Relapsed AML]] | [[Acute myeloid leukemia medical therapy#Supportive Therapy|Supportive Therapy]]
 ==See also==

v t e Myeloid Hematological malignancy/leukemia histology (ICD-O 9590-9989, C81-C96, 200-208)
CFU-GM/ and other granulocytes	Template:Navbox subgroup
MEP	Template:Navbox subgroup
CFU-Mast	Mastocytoma (Mast cell leukemia, Mast cell sarcoma, Systemic mastocytosis)
Multiple/unknown	AML (Acute panmyelosis with myelofibrosis, Myeloid sarcoma) · MP (Myelofibrosis) · Acute biphenotypic leukaemia
See also hematology, lymphoid malignancy